Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and ...

Authors who publish open access in Oncogene are required to ... eligibility and discover whether this journal is included. OA articles in Springer Nature journals are published under Creative ...

Here, the authors show that bromodomain-containing protein 4 is recruited to the MYC enhancer by Mediator and activates transcription through elongation factors independently of bromodomains. This ...

Oncogene adheres to Springer Nature’s Data Policy Type 3. This means that a submission to the journal implies that materials described in the manuscript, including all relevant raw data ...

The journal strongly encourages that all datasets ... additional supporting files whenever possible. Please see Springer Nature’s information on recommended repositories. General repositories ...

Papers should be submitted via the Journal's online submission system ... the form will result in delay of publication. Springer Nature does not require authors of original research papers ...

Oncogene is read by scientists from diverse ... The training is delivered by Nature Research journal editors and aims to help institutions and laboratories support their researchers in writing ...

(A) Oncogene mutations were grouped together when they occurred within a given gene (e.g., 'KRAS' for all mutations in 'KRAS') or in the same functional domain of the encoded protein (e.g ...

Oncogene and Springer Nature are pleased to share our online ... consider whether the topic seems to fit the scope of the journal and is likely to be of sufficient general interest for publication.

Our reviewers are essential in supporting the publication process of Oncogene. Their knowledge ... oncology and endocrinology journals (American Journal of Pathology, Molecular Cancer Research ...

Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and ...